ANXA5 and heart failure: Annexin A5 has been proposed as an imaging biomarker of CV risk since preclinical and clinical studies showed that exposure of PS on the cell surface in the CVS is an attractive biological target in atherosclerosis, heart failure, and cardiac ischemia [51].